ON DEMAND ANALYSIS REQUESTED BY FOLLOWER ⚡️ GIGA 4H TIMEFRAME UPDATE ? Solana Memecoin Gigachad suffered correction after its astronomical run ANY THOUGHTS ON GIGA ?
OANDA:XPTUSD has reached a major resistance zone, where sellers have previously taken control. The current rally has been strong, but this level could act as a turning point if buyers start losing momentum. If we see bearish confirmation—such as rejection wicks, bearish engulfing candles, or a drop in volume—I anticipate a move toward $971.78 level. A clear rejection here could fuel selling momentum, leading to further downside. However, if price breaks and holds above the zone, the bullish trend could extend higher. This is not financial advice but rather how I approach support/resistance zones. Remember, always wait for confirmation, like a rejection candle or volume spike before jumping in. Please boost this post, every like and comment drives me to bring you more ideas! I’d love to hear your perspective in the comments. Best of luck , TrendDiva
Bitcoin’s daily chart shows a strong move higher, breaking above the descending trendline that had been in place since the recent all-time high. This breakout suggests a shift in momentum back to the bulls. Yesterday’s candle closed near the highs, indicating sustained buying pressure throughout the session. The price is now challenging the key resistance level at 106,099, a critical area to watch. A daily close above this level could signal a continuation of the uptrend and open the door for a retest of the all-time high at 109,358. On the downside, support remains firm at 99,860, which aligns closely with the 50-day moving average and continues to act as a safety net for the bulls. Volume has picked up slightly during this breakout, which adds confidence to the move. However, a confirmed breakout requires follow-through, so today’s close will be crucial to assess whether this momentum can be sustained. Traders will be watching for a clean close above resistance or a potential pullback to retest the trendline or support levels below.
On the daily I can see that we are at the end of this possible falling wedge, that if it breaks upward can be bullish. RSI and SRSI ar both at the bottom
Stock is in uptrend. Monthly Rsi shows buyers are in control. Stock hold upper levels for decent time and making news highs at this market correction .. when majoriy of stocks beaten down by also 40 to 50% this holds All time high with conviction. Risk to rewards holds good equation to buy his script.
Join our community and start your crypto journey today for: In-depth market analysis Accurate trade setups Early access to trending altcoins Life-changing profit potential Let's analyse SUIUSDT both fundamentally and technically. FUNDAMENTAL ANALYSIS: SUI is a promising blockchain platform developed by Mysten Labs. Known for its high throughput, scalability, and focus on developer experience, SUI aims to provide a robust infrastructure for decentralized applications. Key features of SUI include: High Performance: Handles a large number of transactions per second. Smart Contracts: Supports self-executing contracts for building dApps. Developer-Friendly: Offers a user-friendly environment for developers. Security and Efficiency: Prioritizes security and efficient transaction processing. SUI's innovative approach could position it as a leading player in the blockchain space. TECHNICAL ANALYSIS: SUI has seen a huge price increase, rallying by about 120% after it broke through the $2.34 resistance level. It's now testing this previous resistance as a new support level, which is further strengthened by the 50-day EMA on the 3-day chart. Buying Levels: $3.7 to $3.3 $2.3 to $2.1 Target Levels: $5.18 $7.01 $11.09 $14.5 If you find this analysis helpful, please hit the like button to support my content! Share your thoughts in the comments and feel free to request any specific chart analysis you’d like to see. Happy Trading!!
Teva Pharmaceuticals, in a groundbreaking collaboration with Sanofi, has unveiled results from the Phase 2b RELIEVE UCCD study that could potentially reshape the landscape of inflammatory bowel disease (IBD) treatment. The study's focus, duvakitug, a novel anti-TL1A monoclonal antibody, has shown remarkable efficacy in managing ulcerative colitis and Crohn's disease, positioning it as a potential best-in-class therapy. With clinical remission and endoscopic response rates significantly outpacing placebo, this development not only challenges existing treatment paradigms but also ignites a spark of hope for millions suffering from these chronic conditions. The implications of duvakitug's success extend beyond immediate patient care; they invite a broader discussion on innovation in the pharmaceutical industry. Teva's strategic pivot towards growth through pioneering drug development efforts underscores a commitment to expanding its portfolio and accelerating access to life-altering treatments. This study's outcomes, showing a favorable safety profile alongside its efficacy, encourage reevaluating how we approach IBD, potentially leading to a future where patients can achieve remission with fewer side effects and less invasive interventions. Moreover, the financial and strategic narrative surrounding Teva's performance in 2024 adds another layer of intrigue. With a notable increase in revenue driven by key products and a focus on both generics and innovative medicines, Teva is not just navigating but also setting the course for future healthcare advancements. The journey of duvakitug from clinical trials to potential Phase 3 trials exemplifies how scientific curiosity, when supported by strategic foresight, can lead to transformative outcomes in medical science, challenging us to imagine a new era in IBD management.
LSEG has launched LSEG Research & Insights, a centralized app within LSEG Workspace that provides seamless access to research and market intelligence. The app consolidates proprietary research, delivering insights across multiple asset classes and financial topics.
Agne Linge, Head of Growth at WeFi, a decentralized finance (DeFi) platform, emphasized the importance of stablecoins during a panel discussion on “Web3: The Economy of the Future” at the World Economic Forum Summit in Davos, Switzerland.” Agne Linge noted that stablecoins, with a total market capitalization of $216 billion, have become a crucial financial […]
CME Group has announced the introduction of options on Bitcoin Friday futures, with the launch scheduled for February 24, pending regulatory approval. These new contracts will be the first CME Group cryptocurrency options to be financially settled, with expirations available every business day from Monday through Friday.